A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data.

Yikuan DuMengting ZhangZhenjie WangMianda HuDongxia XieXiuzhu WangZhuoming GuoJinfeng ZhuWeichui ZhangZiyi LuoChun Yang

Published in: Journal of diabetes investigation (2024)

This study identified many unexpected signals of serious adverse reactions, suggesting the importance of continuous post-marketing surveillance of semaglutide to understand its potential risks.

Keyphrases

adverse drug
public health
electronic health record
emergency department
machine learning
data analysis